Back to Search
RENEE JOYCE, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1528862448Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).
PMID 12736227·Ann Oncol·2003
3-trial
Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.
PMID 11486404·Eur J Haematol Suppl·2001
3-trial
Reported care quality in federal Ryan White HIV/AIDS Program supported networks of HIV/AIDS care.
PMID 19484615·AIDS Care·2009
4-observational
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
PMID 19344412·Br J Haematol·2009
3-trial
Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.
PMID 18261838·Exp Hematol·2008
8-other
A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab.
PMID 18854285·Clin Lymphoma Myeloma·2008
5-case
Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response.
PMID 18326576·J Bacteriol·2008
8-other
Chemical and archaeological evidence for the earliest cacao beverages.
PMID 18024588·Proc Natl Acad Sci U S A·2007
8-other
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
PMID 17545538·Clin Cancer Res·2007
3-trial
False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization.
PMID 17053400·Clin Nucl Med·2006
5-case
Extravazation of therapeutic yttrium-90-ibritumomab tiuxetan (zevalin): a case report.
PMID 16706630·Cancer Biother Radiopharm·2006
5-case
US Environmental Protection Agency Method 314.1, an automated sample preconcentration/matrix elimination suppressed conductivity method for the analysis of trace levels (0.50 microg/L) of perchlorate in drinking water.
PMID 16529757·J Chromatogr A·2006
4-observational
Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
PMID 15744240·Biol Blood Marrow Transplant·2005
3-trial
Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma.
PMID 15453924·Clin Lymphoma·2004
3-trial
Associations between perinatal interventions and hospital stillbirth rates and neonatal mortality.
PMID 14711857·Arch Dis Child Fetal Neonatal Ed·2004
8-other
A comparison of methods of adjusting stillbirth and neonatal mortality rates for birthweight in hospital and geographical populations.
PMID 12675777·Paediatr Perinat Epidemiol·2003
4-observational
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
PMID 12011122·J Clin Oncol·2002
3-trial
Predictors of obstetric intervention rates: case-mix, staffing levels and organisational factors of hospital of birth.
PMID 12554248·J Obstet Gynaecol·2002
8-other
Adjusted mortality rates: a tool for creating more meaningful league tables for stillbirth and infant mortality rates.
PMID 12407470·Public Health·2002
4-observational
Determination of anions at trace levels in power plant water samples by ion chromatography with electrolytic eluent generation and suppression.
PMID 12108643·J Chromatogr A·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 667-7000
Quick Facts
- NPI
- 1528862448
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile